David Papadopoli

1.8k total citations
16 papers, 821 citations indexed

About

David Papadopoli is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, David Papadopoli has authored 16 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in David Papadopoli's work include Metabolism, Diabetes, and Cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and RNA modifications and cancer (3 papers). David Papadopoli is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and RNA modifications and cancer (3 papers). David Papadopoli collaborates with scholars based in Canada, United States and Australia. David Papadopoli's co-authors include Ivan Topisirović, Julie St‐Pierre, Shawn McGuirk, Michaël Pollak, Vincent Giguère, Simon‐Pierre Gravel, Jason J. Northey, Radia Marie Johnson, Matthew G. Annis and Urshila Sriram and has published in prestigious journals such as Nature Communications, Molecular Cell and Nature Cell Biology.

In The Last Decade

David Papadopoli

14 papers receiving 818 citations

Peers

Countries citing papers authored by David Papadopoli

Since Specialization

Citations

This map shows the geographic impact of David Papadopoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Papadopoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Papadopoli more than expected).

Fields of papers citing papers by David Papadopoli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Papadopoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Papadopoli. The network helps show where David Papadopoli may publish in the future.

Co-authorship network of co-authors of David Papadopoli

This figure shows the co-authorship network connecting the top 25 collaborators of David Papadopoli. A scholar is included among the top collaborators of David Papadopoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Papadopoli. David Papadopoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Epigenetic alterations facilitate transcriptional and translational programs in hypoxia 2025 ·Nature Cell Biology ·Kathleen Watt, Bianca Dauber, Krzysztof J. Szkop, Laura Lee, (unknown), Shan Chen, (unknown), (unknown), Tyler T. Cooper, David Papadopoli, Laìa Masvidal, Michael Jewer, Kristofferson Tandoc, Howard K. Plummer, Gilles Lajoie, Ivan Topisirović, Ola Larsson, Lynne‐Marie Postovit	0
2	MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors 2024 ·iScience ·(unknown), (unknown), David Papadopoli, Predrag Jovanović, (unknown), Daina Avizonis, Masahiro Morita, (unknown), Josie Ursini‐Siegel, Lynne‐Marie Postovit, Michael Witcher, Ivan Topisirović	5
3	The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma 2023 ·Blood Advances ·(unknown), Remya Nair, Ronald A. Merrill, (unknown), (unknown), (unknown), (unknown), Catherine St‐Louis, David Papadopoli, Ivan Topisirović, Julie St‐Pierre, Michaël Sébag, Aparna H. Kesarwala, Laura Hulea, Eric B. Taylor, Mala Shanmugam, Alexandre Orthwein	9
4	Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids 2022 ·Cell Reports ·(unknown), (unknown), (unknown), David Papadopoli, Cian Monnin, (unknown), (unknown), (unknown), (unknown), (unknown), Zahra Rattray, Nicholas J. W. Rattray, Sheela A. Abraham, Eeva‐Liisa Eskelinen, David G. Watson, Daina Avizonis, Ivan Topisirović, Edmond Y. W. Chan	25
5	Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells 2022 ·FEBS Open Bio ·(unknown), Alexander V. Zhdanov, (unknown), Predrag Jovanović, Ye Wang, Dmitry E. Andreev, Laura Hulea, David Papadopoli, Daina Avizonis, Pavel V. Baranov, Michaël Pollak, Dmitri B. Papkovsky, Ivan Topisirović	7
6	Perturbations of cancer cell metabolism by the antidiabetic drug canagliflozin 2021 ·Neoplasia ·David Papadopoli, (unknown), (unknown), (unknown), Laura Hulea, Ivan Topisirović, Michaël Pollak, Julie St‐Pierre	40
7	Cell size homeostasis is maintained by CDK4-dependent activation of p38 MAPK 2021 ·Developmental Cell ·(unknown), Miriam B. Ginzberg, (unknown), (unknown), Shixuan Liu, David Papadopoli, John Concannon, Yuan Wang, Douglas S. Auld, Jeremy L. Jenkins, Hannes Röst, Ivan Topisirović, Andreas Hilfinger, W. Brent Derry, Nish Patel, Ran Kafri	33
8	The role of GSK3 in metabolic pathway perturbations in cancer 2021 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·David Papadopoli, Michaël Pollak, Ivan Topisirović	39
9	Methotrexate elicits pro-respiratory and anti-growth effects by promoting AMPK signaling 2020 ·Scientific Reports ·David Papadopoli, H. Eric, Dominic G. Roy, (unknown), Gaëlle Bridon, Daina Avizonis, Russell G. Jones, Julie St‐Pierre	11
10	Cancer Plasticity: The Role of mRNA Translation 2020 ·Trends in cancer ·Laura Lee, David Papadopoli, Michael Jewer, Sonia V. del Rincón, Ivan Topisirović, Mitchell G. Lawrence, Lynne‐Marie Postovit	50
11	Genome-Wide Screens Reveal that Resveratrol Induces Replicative Stress in Human Cells 2020 ·Molecular Cell ·(unknown), Thierry Bertomeu, Jasmin Coulombe‐Huntington, (unknown), María Sánchez‐Osuna, David Papadopoli, Daina Avizonis, (unknown), Caroline Huard, Ivan Topisirović, Hugo Würtele, Mike Tyers, Lea Harrington	22
12	Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer 2020 ·Nature Communications ·Léo Aubert, Neethi Nandagopal, Zachary Steinhart, Geneviève Lavoie, Sami Nourreddine, Jacob M. Berman, Marc K. Saba-El-Leil, David Papadopoli, Sichun Lin, Traver Hart, Graham MacLeod, Ivan Topisirović, Louis Gaboury, Christoph J. Fahrni, Daniel Schramek, Sylvain Meloche, Stéphane Angers, Philippe P. Roux	200
13	The impact of AMPK signalling and clinical therapeutics on cancer metabolism 2019 ·eScholarship@McGill (McGill) ·David Papadopoli	0
14	PGC-1α Promotes Breast Cancer Metastasis and Confers Bioenergetic Flexibility against Metabolic Drugs 2017 ·Cell Metabolism ·Sylvia Andrzejewski, Eva Klimčáková, Radia Marie Johnson, Sébastien Tabariès, Matthew G. Annis, Shawn McGuirk, Jason J. Northey, Valérie Chénard, Urshila Sriram, David Papadopoli, Peter M. Siegel, Julie St‐Pierre	186
15	The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer 2016 ·Cell Reports ·Étienne Audet‐Walsh, David Papadopoli, Simon‐Pierre Gravel, Tracey Yee, Gaëlle Bridon, Maxime Caron, Guillaume Bourque, Vincent Giguère, Julie St‐Pierre	73
16	PGC-1α supports glutamine metabolism in breast cancer 2013 ·Cancer & Metabolism ·Shawn McGuirk, Simon‐Pierre Gravel, Geneviève Deblois, David Papadopoli, Brandon Faubert, André Wegner, Karsten Hiller, Daina Avizonis, Uri David Akavia, Russell G. Jones, Vincent Giguère, Julie St‐Pierre	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact